Chemokine-like factor 1 (CKLF1) is a novel cytokine first cloned from U937 cells. It contains different splicing forms and has chemotactic effects on a wide spectrum of cells both in vitro and in vivo; it can also stimulate the regeneration of skeletal muscle cells in vivo, but the mechanism remains unclear. To probe the myogenesis function of CKLF2, which is the largest isoform of CKLFs, C2C12 murine myoblasts were stably transfected with human CKLF2 eukaryotic expression vector. Compared with control vector transfected C2C12 cells, CKLF2 overexpression causes accelerated myoblast proliferation as determined by cell counting and [ 3 H]TdR incorporation assays. In addition, CKLF2 overexpression also promotes cell differentiation, which was determined by higher expression levels of myogenin, creatine kinase, myosin and the accelerated myoblast fusion. Further analysis also indicates that CKLF2 could activate the transcription activity of the bHLH/ MyoD and MEF2 families. Finally, DNA synthesis and myotube formation could also be promoted by growing C2C12 cells in conditioned media from CKLF2-transfected cells. These findings strongly suggest a role for human CKLF2 in regulation of skeletal muscle myogenesis. D
Introduction
Chemokine-like factor 1 (CKLF1) is a novel cytokine isolated in our laboratory, which has at least three isoforms, CKLF2, CKLF3 and CKLF4, of which CKLF2 is the fulllength cDNA product. Our previous studies showed that CKLF1 could attract monocytes, lymphocytes and neutrophils both in vitro and in vivo and stimulate the regeneration of skeletal muscle cells in vivo. The enhancing effect on satellite cells may be caused directly by CKLF1 or the cytokines secreted by the attracted leukocytes [1] .
Satellite cells are small mononuclear cells first identified by Mauro [2] lying under the basal lamina of the myofiber. These cells are present in muscle mostly in their quiescent state. Nevertheless, upon muscle injury, satellite cells become mitotically active, displaying programmed proliferation and differentiation followed by expression of musclespecific proteins [3, 4] .
The extracellular factors that activate quiescent satellite cells and regulate their proliferation and differentiation processes during muscle growth and regeneration have not been completely elucidated. Nevertheless, several growth factors have been implicated in stimulating or inhibiting satellite cell growth. Growth factors such as fibroblast growth factor (FGF) or hepatocyte growth factor (HGF) promote the proliferation but inhibit the differentiation of muscle cells, with the exception of insulin-like growth factor 1 (IGF-1), which displays promoting activity on both proliferation and differentiation of muscle cells [5 -8] .
Molecular mechanisms controlling myogenesis at the transcriptional level have been well characterized. The differentiation of skeletal muscle cells involves the expression and activation of two major transcription factors: basic helix-loop -helix (bHLH) family and myocyte enhancer factor 2 (MEF2) family. The bHLH family contains MyoD, Myf5, myogenin and myogenic regulatory factor-4 (MRF4) [9] , while MyoD and Myf-5 are expressed in the myoblast cells prior to the onset of muscle differentiation [9 -12] ; once activated, MyoD and Myf5 induce the expression of myogenin and MRF4, as well as the other important transcription factors of the MEF2 family.
MEF2 cooperates with bHLH family members in the activation of many muscle structural genes [13, 14] . Members of the MEF-2 family of transcription factors play a critical role in the activation of contractile protein transcription. The MEF-2 family is encoded by four independent genes, MEF2A, MEF2B, MEF2C and MEF2D [14] . MEF-2 proteins and DNA-bound bHLH factors synergistically regulate transcription by cooperative mechanisms that involve direct physical association [15] . In mammalian animals, MEF2A, MEF2B and MEF2D are ubiquitously expressed, whereas MEF2C is restricted to skeletal muscle and brain, MEF2C DNA-binding activity is highly enriched in muscle and neural tissue.
In this study, we transfected C2C12, a mouse satellite cell line, with human CKLF2 expression vector to analyze the effects and possible mechanisms of CKLF activity on the proliferation and differentiation of muscle cells. This cell line was selected since it is a pure, immortalized mouse satellite cell line, which is morphologically similar to primary satellite cell cultures [16 -18] . Moreover, unlike other muscle cell lines, e.g. L6 cells, C2C12 cells have an unrestricted profile of myogenic factor expression, including Myf-5, myogenin, MRF-4 and MyoD. Here, we demonstrate that overexpression of CKLF2 in C2C12 accelerates transcription of several muscle-specific genes, myosin lightchain 2 (MLC2) and muscle creatine kinase (MCK), both in the serum-rich and low-level serum medium. The study also indicates that expression of CKLF2 enhances cell proliferation. The in vitro transfection assays provide evidences that the muscle-stimulating effect of CKLF2 is independent of other cytokines. Therefore, CKLF2 may directly participate in the regeneration of muscle cells.
Materials and methods

Materials
The C2C12 cell line was purchased from ATCC. The plasmid of pcDNA3.1/Myc-HisB( À ) was obtained from Invitrogen Life Technologies (Carlsbad, CA). The luciferase reporter plasmid of pGL3-Basic and the Luciferase assay system was from Promega (Madison, WI). A SUPER-SCRIPTk first-Strand Synthesis System for RT-PCR, Tri-zol, Dulbecco modified Eagle medium (DMEM), horse serum (HS) and G418 were obtained from Invitrogen Life Technologies. Anti-mouse myogenin monoclonal antibody (F5D) from BD Biosciences Pharmingen (San Diego, CA) was used. Anti-Myosin heavy chain (MF20) was from DSHB (The University of Iowa, Iowa City, IA). Fetal calf serum was purchased from Hyclone (Logan, UT). fluorescein isothiocyanate (FITC)-phalloidin and creatine phosphokinase assay kits were provided by Sigma-Aldrich Corp. (St. Louis, MO). SYBR Green PCR Core Reagent for realtime PCR was gotten from Applied Biosystems (Foster City, CA).
Plasmids
To construct the eukaryotic expression vector, the fragment containing the complete CKLF2 ORF was released from the recombinant plasmid pGEM-T -CKLF2 [1] by cutting with EcoRI and subcloned into the EcoRI site of pcDNA3.1. The sense pcDNA3.1-CKLF2 was selected by restriction enzyme analysis and the CKLF2 insert was confirmed by DNA sequencing.
The reporter plasmid of pGL3 myogenin containing myogenin promoter was constructed according to the paper described by Yee and Rigby [19] . 4RE-tK-Luc that contains four copies of E-box and 3 Â MEF2-tK-Luc that contains three copies of MEF2 binding sites were kindly provided by Dr. Zhenguo Wu [20] and have been described elsewhere [21, 22] .
Cell culture
Mouse myoblast cell line C2C12 was maintained as subconfluent monolayers in DMEM containing 4.5 g/l glucose and 4 mM L-glutamine supplemented with 15% fetal bovine serum (FBS), 100 U/ml penicillin and 100 Ag/ ml streptomycin. To induce differentiation, the medium was changed to DMEM supplemented with 1% horse donor serum. During cell differentiation, the medium was changed every day.
Stable transfection and isolation of clones
C2C12 cells were plated at 12,000 cells/60-mm-diameter tissue culture dish a day before cells were transfected with 5 Ag plasmid DNA by calcium phosphate precipitation procedure [23] . Two days later, cells were washed and plated onto a 100-mm diameter dish in growth medium (GM) containing 400 Ag/ml of G418. Selection proceeded for 2 weeks; the medium was changed every 3 days. The G418resistant clones were harvested and analyzed.
Cell proliferation assay
Cells were plated in six-well plates (8000 cells/well) and cultured continuously for 5 days. Cells were detached from the plate with 0.25% trypsin -EDTA and then resuspended in PBS with 0.4% trypan blue. Viable cells as determined by trypan blue exclusion were counted using a hemocytometer [24] . Plating efficiency was controlled to avoid significant variation among groups in this experimental protocol.
Thymidine incorporation
DNA synthesis was assessed by [ 3 H]thymidine incorporation. Cells were plated onto a 96-well plate 24 h before [ 3 H]thymidine was added (1 ACi/ml) for an additional 6 h incubation. Cells were harvested by TOMTEC Harvester 96R onto a 96-well Filtermat (Perkin Elmer, Torrance, CA). The incorporation of [ 3 H]thymidine was determined by MicroBeta Windows Workstation (Perkin Elmer).
Cell cycle analysis
When C2C12/CKLF2 and C2C12/Vector cells reached 70 -80% confluence, they were washed with PBS, detached with 0.25% trypsin -EDTA and fixed with 75% ethanol overnight. Samples were washed and resuspended in 0.5 ml PBS and RNA was eliminated by digestion with RNaseA for 30 min. Before the DNA contents were measured by fluorescence-activated cell sorting (FACS) on a Becton-Dickinson FACScan flow cytometry system, cells were stained with propidium iodide (PI) in the dark for 30 min. The data were analyzed using CellFIT software.
RNA isolation and quantitative real-time RT-PCR
Total RNA was isolated from cell cultures using Trizol reagent. Reverse transcription (RT) was performed using a SUPERSCRIPTk first-Strand Synthesis System according to the user manual. Quantitative real-time PCR assay was carried out in an ABI PRISM 7700 Sequence Detection System (Applied Biosystems) to assess expression of MLC2 and MCK. PCR reactions were performed according to the user manual. Preliminary reactions were run to optimize the concentration and ratio of each primer set. The purpose of this procedure is to determine the minimum primer concentrations giving the maximum DR n and minimum nonspecific amplification. The pure DNA probe of interest was used as template to generate a standard curve. The 7700 program consisted of one AmpErase UNG incubation (50 jC, held 2 min), followed by 95 jC for 10 min to activate AmpliTaq Gold and inactivate AmpErase UNG, then 40 cycles of 95 jC for 15 s, then 60 jC for 1 min. Each pair of primers have 2 jC or less difference in T m and generate a product around the optimal range (500 bp) for SYBR Green I dye quantification. The sequences of the primers used are listed in Table 1 . 18S rRNA was included as the internal control for each cDNA sample.
Cell labeling with phalloidin
In order to observe the formation of myotubes in differentiated cells, filament actin was stained with FITC-phalloidin. Immunofluorescence was carried out as described by Chen et al. [25] . Briefly, at indicated days of differentiation, cells cultured on a 24-well plate were rinsed with cold PBS (PH7.4) and fixed with 2% paraformaldehyde and 0.1% Triton X100, then the cells were rinsed again and stained with FITC -phalloidin (Sigma) at 200 ng/ml at room temperature for 30 min. Hoechst 33258 nuclear dye was added with FITC -phalloidin at a final concentration of 500 ng/ml. Fluorescent images were captured on an Olympus fluorescent microscope with a coupled charged device (CCD) camera.
Creatine kinase assay
Muscle creatine kinase activity assay was performed according to the manual provided with a Sigma Creatine Phosphokinase assay kit. The procedure was adapted to a 96-well microplate assay. Briefly, deionized water was added to each vial to dissolve the NADH-containing substrate, cell extract was added, mixed and absorbance at 340 nm was measured every minute. For each well, 300 Al of substrate and 10 Al of cell extract were added. The OD 340 nm absorbance was measured on a POLARstar galaxy (BMG Labtechnologies Pty. Ltd., Mornington, Victoria, Australia) spectrometer. In each test, cell extracts were quantified and normalized to equal concentration.
Western blot analysis
Nuclear proteins were extracted from myoblasts and myotubes as previously described [26] . Protein concentration was determined using a Coomassie Plus Protein Assay Reagent Kit (Pierce Chemical Corp., Rockford, IL). Proteins were separated on SDS-PAGE and transferred to Hybond-ECL membranes (Amersham Biosciences, Inc., Piscataway, NJ). The membranes were reacted with primary antibodies and then HRP-conjugated anti-mouse IgG (Promega). Proteins were detected by ECL Western Blotting Detection Reagent (Pierce). Table 1 PCR primers used for real-time PCR analysis Forward Reverse 18S RNA 5V -TCG AAC GTC TGC CCT ATC AA-3V 5V -GCT ATT GGA GCT GGA ATT ACC G-3V MLC2
5V -ATG GCA CCC AAG AAG GCC AA-3V 5V -CTA TTC CTG GTC CTT AGC ATC-3V MCK 5V -ACC TGG ACC CCA ACT ATG TG-3V 5V -ATC ATG TCG TCG ATG GAC TG-3V
DNA transient transfection and luciferase assays
C2C12 cells were seeded at 1.5 Â 10 5 cells/well onto sixwell plates in triplicates. On the following day, cells were transfected with various reporter plasmids, as indicated in the figures. Two hundred nanograms of the pEGFP-N1 plasmid (BD Biosciences Clontech, Palo Alto, CA) were included in transfections as an internal control for transfection efficiency. Luciferase activities were determined in aliquots of cell extracts from harvested cells 48 h after transfection in GM and 24 h after being switched to differentiation medium (DM). Luciferase activity was assayed using a Luciferase Assay System (Promega) according to the manufacturer's instructions. All luciferase activities were determined and designated as relative luminescence units (RLU) by POLARstar galaxy spectrometer. The results were normalized with equivalent quantities of GFP proteins.
Paracrine effects of CKLF2
In addition to the above studies, we also probed the paracrine effects of CKLF2 as described [27] , we seeded wild C2C12 cells in a 96-well plate, and cultured them in 75% CKLF2-conditioned medium and control conditioned medium. After 48 h, cell proliferation was evaluated by
For the cell differentiation assay, CKLF2-conditioned medium were added at the proliferation stage, and switched to CKLF2-conditioned DM when cells reached 80% confluence. Medium was changed every 24 h. Forty-eight hours later, myotubes were observed and images were captured with a CCD camera.
Statistical analysis
The S.D. (standard deviation) in results are presented as means of multiple (three to six) replicate cultures within each treatment group and results are presented for a single representative experiment. Observations were confirmed in at least three independent experiments using different cell preparations. Student's t-test was employed to assess the significance of differences between different treatment groups. Statistical significance was set at P < 0.05.
Results
Generation of C2C12 myoblast cell lines overexpressing CKLF2
To study how CKLF2 affects the proliferation and differentiation of myoblasts, we generated C2C12 cell lines expressing CKLF2 and a control C2C12 cell line containing the pcDNA3.1 vector. Cells were drug-selected and survival clones were collected. Four G418 resistant clones were randomly selected and analyzed for the expression level of CKLF2 by semiquantitative RT-PCR. CKLF2 mRNA expression differed somewhat between several different CKLF2 positive clones and was not detectable in control cells (designated as C2C12/Vector). Since clone 1 and 2 displayed similar processes of differentiation, clone 1 (designated as C2C12/CKLF2) that had the highest expression level of CKLF2 was further analyzed as the representative (Fig. 1 ).
Morphological changes and differentiation induced by overexpression of CKLF2 in serum-rich medium
Myoblasts transfected with CKLF2 appeared flat, enlarged and the spontaneous myotubes were distinct, while those transfected with the empty vector displayed no such changes in GM. In order to evaluate the activation of CKLF2 on myogenesis in serum-rich medium, we cultured cells continuously in serum-rich medium after they reach confluence. As is shown in Fig. 2A , when cells were cultured in serum-rich medium for another 2 days after they reached confluence, distinct myotube formation was observed in C2C12/CKLF2 cells, while no such phenomena except cell elongation and aligning were found in the control cells. Western blot analysis (Fig. 2B ) revealed that myogenin expression was barely detectable in control C2C12 myoblasts; in contrast, C2C12/CKLF2 cultures activated myogenin expression at the myoblast stage. This likely reflects the increase in differentiation of C2C12 cells by CKLF2 and we cannot exclude the possibility that CKLF2 exerts its action by promoting cell proliferation.
Overexpression of CKLF2 promotes the proliferation of C2C12 cells
In the normal cultures, we found C2C12/CKLF2 cultures often reached confluence 24 h or more before the control transfected cells (data not shown). In order to know if CKLF2 accelerates the differentiation of C2C12s by promoting their proliferation or by promoting both proliferation and differentiation of C2C12 cells, we analyzed the growth curves of C2C12/CKLF2 and C2C12/Vector cells. After being seeded, the control and CKLF2-transfected myoblasts maintained in DMEM plus 15% fetal calf serum were counted at 1, 2, 3, 4 and 5 days. As illustrated in Fig. 3A , myoblasts expressing CKLF2 grown faster than control cells. With the equal initial cells, C2C12/CKLF2 cells were almost three times more than control cells after 4 days culture. These results indicated that CKLF2 could stimulate the proliferation of myoblasts. Cell cycle analysis also indicated there was a significant increase in the number of proliferating cells (G2/ M and S phase) in the C2C12/CKLF2 myoblasts (Fig. 3B) . Consistent with this, CKLF2-stimulated increase in proliferation, DNA synthesis was also increased in the C2C12/ CKLF2 myoblasts, as evidenced by a greater increase in [ 3 H]thymidine uptake in these cells compared with control myoblasts (Fig. 3C ).
Morphological changes and differentiation induced by overexpression of CKLF2 in DM
Since myotubes appeared in myoblasts transfected with CKLF2, we examined whether CKLF2 expression in C2C12 cells could also promote cell differentiation in DM. We stained the cells with FITC-labeled phalloidin and analyzed the morphological phenotype of control cells as well as C2C12/CKLF2 cells as they differentiated. As shown in Fig. 4 , expression of CKLF2 accelerated cell differentiation and generated pronounced myotube hypertrophy. On the second day of switching to DM, extensive and pronounced myotubes were observed in C2C12/CKLF2 cells, while few myotubes were seen in control cells. On the fourth day of differentiation, muscle hypertrophy was seen in C2C12/ CKLF2 cells, while the myotubes in the control cells were fewer and thinner.
Overexpression of CKLF2 promotes the myogenic differentiation of C2C12 cells
Next, we analyzed how CKLF2 affected the differentiation process of C2C12 cells. Myoblasts were induced to differentiate in DM with quantitative real-time RT-PCR and Western blot used to analyze the expression levels of several muscle-specific genes, such as MLC2, myosin heavy chain (MHC) and MCK. The expression level of MLC2, MHC and MCK can represent the differentiation state of cells. The induction of MLC2 and MCK muscle differentiation marker molecules by CKLF2 was confirmed by real-time quantitative RT-PCR (Fig. 5A ). As shown in Fig. 5A , the expression of MLC2 and MCK was induced in both cell lines as a result of their growth in DM. C2C12/CKLF2 cells displayed an increase of the transcripts in MLC2 and MCK compared with control cells. The quantitative data is shown in the table in Fig. 5A . Metabolic evaluation of C2C12 myotubes by creatine kinase assay indicated that creatine kinase activity was elevated in CKLF2-transfected cells (Fig. 5B ). Western blot of another myogenic marker, MHC, also showed enhanced and earlier expression in cells expressing CKLF2 (Fig. 5C ).
CKLF2 potentiates the myogenic program by induction of myogenin expression
In order to uncover the mechanism of CKLF2 promoting muscle differentiation, we focused on the expression of the master transcription factor in muscle cells, myogenin. Western blot analysis has shown that CKLF2 could enhance the expression of myogenin in serum-rich medium (Fig. 2B) . So, we also checked the expression of myogenin in differentiated cells. Cell nuclear extracts at different stages were prepared and subjected to Western blot. As illustrated in Fig.  6A , CKLF2 could activate the expression of myogenin of C2C12 cells cultured in DM, which is in agreement with its stimulating effect on the expression of myogenin of C2C12 cells cultured in GM.
We also checked the transcription of myogenin by a reporter plasmid. Yee and Rigby [19] have described that a 133-bp myogenin proximal promoter contained sufficient cis-elements to correctly target a lacZ transgene to specific muscle-forming regions. Furthermore, an E box, an MEF2 site, and an MEF3 site within this 133-bp proximal myo- 3 . CKLF2 promotes the proliferation of C2C12 cells. (A) C2C12 cells were plated in six-well plates for triple wells, and the average cell number was calculated by trypan blue exclusion every day. The time-dependent increase in the number of myoblasts of control and CKLF2-transfected cells is shown ( P < 0.01). At 72 h, there is an approximately three-fold increase in the number of myoblasts transfected with CKLF2 compared with control myoblasts. (B) C2C12/CKLF2 and control cells were cultured in growth medium to 70% confluence, and cells were harvested, fixed and stained with PI. FCS analysis was performed on Becton-Dickinson FACScan flow cytometry system. This graph is a representation of three independent analysis. C2C12/CKLF2 is significant different from control cells ( P < 0.01). (C) [ 3 H]TdR incorporation was determined to evaluate the DNA synthesis. To avoid contract inhibition, we seeded C2C12/CKLF2 and control cells into 96-well plate at different cell density in 2% FCS DMEM. This graph is a representation of three independent experiments and C2C12/CKLF2 is significantly different from control cells ( P < 0.01).
genin promoter have been identified as critical cis-elements regulating myogenin expression [28 -32] . MyoD and MEF2 proteins have been implicated as the nuclear factors binding these cis-elements. We constructed a myogenin promoter-Luc reporter plasmid by cloning the fragment containing the proximal 133 bp upstream of a luciferase gene and checked the transcription of myogenin. The transcription state of myogenin can be represented by luciferase activity. From Fig. 6B , we provided evidence that CKLF2 promoted myogenin expression by increasing the transcription of myogenin.
CKLF2 could activate the transcription activity of BHLH/myoD family and MEF2 family
The above data provide evidences that CKLF2 potentiates the myogenic program by induction of myogenin expression. Are there any other mechanisms involved in this process? In fact, the induction of myogenic differentiation by the MRFs is achieved by interaction with multiple additional transcription factors. Among these, the MEF-2 family is involved in a complex regulatory network with the MRFs [33, 34] .
From the above results, we can conclude that CKLF2 could promote the transcription of several muscle-specific molecules such as MCK and myogenin. As previously reported, E-box and MEF2 box are often in tandem on the promoter of some muscle-specific genes. Does CKLF2 activate the transcription of MEF2C, the main MEF2 family member in differentiated muscle, as well as myogenin? To answer this question, we analyzed the expression of mouse MEF2C by quantitative RT-PCR. We did not observe that MEF2C expression was particularly altered in the CKLF2expressing cells (data not shown). However, MCK, a known target of MEF2C, was stimulated to express at a higher level in C2C12/CKLF2 than in the control C2C12 cultures (Fig.  5A ). As we have known, MCK gene promoter contains an MEF2 binding site, which is essential for its activity in addition to several MRF E-box targets [34] . Fig. 4 . Analysis of morphological changes of C2C12 transfected with pcDNA3.1 -CKLF2. C2C12/CKLF2 cells and the control C2C12 cells were cultured in DM for 4 days after they reached confluence. Cells were fixed and myotubes were identified by staining with FITC -phalloidin at indicated times.
Fig. 5. CKLF2 affects the expression of MLC2, MCK and MHC. (A)
Expression of MLC2 and MCK was determined by real-time PCR. The cDNA samples from C2C12/CKLF2 and control cells were used in realtime PCR reactions as described in Materials and methods. The amount of product for each PCR reaction was calculated from the incorporation of SYBR green, and 18S rRNA was used as a reference and all molecular markers were evaluated as to their abundance with respect to 18S rRNA of that cDNA sample. (B) MCK activities were determined between C2C12/ Vector and C2C12/CKLF2 cells. C2C12/Vector and C2C12/CKLF2 were cultured and induced to differentiation; cell extracts were prepared at indicated times. Results are expressed as the relative CK activity (%) between C2C12/CKLF2 and control cells. CK activity of C2C12/CKLF2 in Day 3 was arbitrarily set at 100%. The error bar means the maximum variation of data. C2C12/CKLF2 is significant different from control cells in Day 3 after induction ( P < 0.01). This graph is a representation of three independent experiments. (C) Expression of myosin heavy chain at indicated times was determined by Western blot. So, we analyzed the transcription activity profile of MEF2 and bHLH/MyoD reporter plasmid in C2C12/Vector and C2C12/CKLF2 cells. We tested the potential of CKLF2 to activate MyoD/bHLH mediated transactivation of an E box/bHLH factor-dependent reporter, 4RE-tK-Luc, and MEF2 mediated transactivation of MEF2 factor-dependent reporter, 3 Â MEF2-tK-Luc. As is expected, we observed the activation of the E box-dependent reporter and MEF2dependent reporter. As is illustrated in Fig. 7 , CKLF2 promoted the transcription activity of bHLH/MyoD and MEF2 simultaneously. And interestingly, the MEF2 reporter was more responsive to CKLF2 than bHLH/MyoD reporter. This suggests that the activation of MEF2C gene expression by CKLF2 reinforces and amplifies its effect on the myogenic program.
CKLF2 acts as a paracrine growth factor
Previous studies have demonstrated that CKLF1 was a secreted cytokine while CKLF2 was not detected from cell supernatant in a transient transfection assay [1] . However, in order to study the paracrine effects of CKLF2, we treated Fig. 7 . CKLF2 activates MEF-2C and bHLH/MyoD-mediated transactivation of muscle-specific gene expression. C2C12/CKLF2 and the control cells were transiently transfected with 4RE-Luc and 3 Â MEF2-Luc reporter gene and induced to differentiation. Cell extract was prepared at indicated time and luciferase assay was performed on POLARstar galaxy luminometer. Fold activation is expressed relative to Luc activity obtained after transfection the 4RE-Luc and 3 Â MEF2-Luc reporter to the C2C12/ vector cells. Activation mediated by control cells is arbitrarily set at 1. Data presented are representative of three independent tests. Luciferase activities in CKLF2-transfected cells are significantly different from those in control cells ( P < 0.01). Fig. 8 . CKLF2 stimulates cell proliferation and differentiation by paracrine effects. (A) Wild type C2C12 cells were cultured in 80% CKLF2 or control conditioned medium for 2 days, and DNA synthesis of different treated cells was accessed by [ 3 H]TdR incorporation. Student's t-test was employed and significant difference exists between the two treated groups ( P < 0.01). (B) Wild C2C12 cells were cultured in exclusively in CKLF2 or control conditioned medium and switched to conditioned DM when cells reached confluence. Differentiation was allowed, and cells were harvested for photography at day 2 after induction. Fig. 6 . CKLF2 promotes the differentiation of C2C12 by enhancing the expression of myogenin. (A) Cells were cultured in differentiation medium at indicated times, nuclear proteins were isolated and subjected to Western blot, 20 Ag protein was loaded in each lane, and the expression of myogenin was detected with the myogenin-specific antibody (F5D, Pharmingen) (B) CKLF2 enhanced myogenin promoter activity. C2C12/vector and C2C12/ CKLF2 myoblasts were transiently transfected with a myogenin-Luc vector. Cell cultures were shifted to differentiation medium 24 h after transfection and cultured for an additional 48 h. Cell extracts were prepared at myoblast (day 0), day 1 and day 2 after induction to differentiation. Luciferase is expressed as relative activity between two groups with control being set at 1. This graph is a representation of three independent experiments, which demonstrated luciferase activity in CKLF2-transfected cells are significantly different from those in control cells ( P < 0.01). wild C2C12 myoblasts with the medium harvested from CKLF2-transfected cells and control conditioned medium. [ 3 H]TdR incorporation was used to evaluate cell proliferation. As is shown in Fig. 8A , CKLF2-treated cells showed enhanced DNA synthesis compared with control. In agreement with our above data, myotube formation and cell contraction were more distinct in CKLF2-treated cells than those observed in control-treated cells. As is seen in Fig. 8B , extensive cell contraction was observed in CKLF2-treated cells, while extensive cell death existed in control-treated cells. These paracrine effects suggested that secreted or shed CKLF2 should exist in the conditioned medium, although we could not exclude the intracellular function of CKLF2. These results demonstrate the paracrine role of CKLF2 in mediating the process of cell proliferation and myotube differentiation.
Discussion
CKLF1 is a novel cytokine having a unique structure and multiple activities. We have demonstrated that CKLF1 may participate in a wide range of physiological processes including stimulating the regeneration of skeletal muscle cells in vivo. In our last paper, we put forward three possible mechanisms by which CKLF1 could regulate muscle regeneration: firstly, CKLF1 itself has promoting effects on the proliferation and differentiation of skeletal muscle satellite cells in the same way as IGF-1; secondly, the leukocytes attracted by CKLF1 produce different kinds of cytokines when activated, which influence the growth of myogenic cells; thirdly, CKLF1 has a synergistic action with some of the secreted cytokines to increase the rate of cellular proliferation and the formation of myotubes.
To gain insight into the mechanism underlying the stimulatory effect of CKLF on muscle regeneration in vivo [1] , we focused our analysis on the mouse satellite cell line, C2C12, in an in vitro transfection assay by investigating the direct involvement of CKLF in regulation of muscle cell proliferation and differentiation. Preliminary studies showed that the rat and mouse homologue of CKLF2 may participate in the growth of muscle cells and that murine and rattus CKLF2 were upregulated accompanied with musclespecific molecule markers upon serum-deprivation in mouse or rat primary satellite cells (data not shown). So, we established the stable C2C12 cell line that expressed CKLF2, the largest isoform, under a CMV promoter to study CKLF2's activities on the muscle cells.
Our data provide evidences that overexpression of human CKLF2 in C2C12 cells potentiates and accelerates the proliferation and myogenic program, inducing dramatic myotube hypertrophy. This action may be dependent on the upregulation of myogenin and transactivation of bHLH/MyoD and MEF2C. MEF2C, the main MEF2 member in differentiated muscle cells, did not show any particular change of RNA transcripts in C2C12/CKLF2 cells, which is inconsistent with the fold activation of MEF2 transcription activity. The disparity between MEF2 activity and mRNA levels has been reported previously in MEF2 family members. Suzuki et al. [35] have reported that in vascular smooth muscle cells, MEF2A protein levels dramatically increase in response to serum stimulation, without a corresponding change in mRNA levels. Previous researches have demonstrated that various signaling systems are implicated in the control of MEF2 activity. Several cofactors including members of bHLH family have been identified to modulate the activity of MEF2 by protein interaction. For example, bHLH factors, pRb [36] and p300 [37] could stimulate the activity of MEF2 by physical interaction; MITR [38] , Twist [39] and HDAC [40] factors act as inhibitory cofactors. Mitogen-activated protein kinases play a pivotal role in regulation of MEF2 activity by protein phosphorylation and the calcium/calmodulin-dependent phosphatase, calcineurin, stimulates MEF2 transcriptional activity by inducing a cofactor or a posttranslational modification of MEF2 that potentiates transcriptional activity [41 -46] . Therefore, we postulate that CKLF2 could activate MEF2 through other mechanisms that exclude RNA transcription. Further analysis will answer this question and elucidate these mechanisms and signaling pathway.
Although previous studies did not detect CKLF2 in supernatant by Western blot, this study determines the paracrine effects of CKLF2, it suggests CKLF2 acts as a paracrine growth factor in this system. We also have cloned the mouse and rat homologue of CKLF2 simultaneously, and found both rat CKLF2 and mouse CKLF2 contained a CX3C motif in their C-terminal regions [unpublished data] while human CKLFs contained a CC motif in the same region. So, we postulate CKLFs are bridge molecules between CC chemokines and CX3C chemokines. Tsou et al. [47] have reported tumor necrosis factor-converting enzyme (TACE) could cleave the membrane-bound fractalkine, the only member of CX3C chemokine, and result in a soluble form of fractalkine that is also a potent chemoattractant for lymphocyte cells. Therefore, we postulated that CKLF2 could be processed into the soluble form. Also, Uruno et al. [48] reported distinct regulation of myogenic differentiation by intracellular and extracellular FGF-1 (aFGF). They found that endogenous FGF-1 did not suppress myoblast differentiation while FGF-1 protein in culture medium suppressed it. So, we could not exclude some regulation of the intracellular function of CKLF2. Further studies are underway to elucidate this mechanism.
From our previous data, we hypothesized a role for CKLF2 in the establishment and maintenance of the mature muscle phenotype in normal and regenerating muscle tissue. From this paper, we can conclude that CKLF2 may exert double effects on the mouse satellite cell line, C2C12. With its proliferation-promoting effect on the growing cells and its myogenic-promoting effect on the postmitotic cells, CKLF2 is another protein, which has a double action on muscle cells, besides IGF-1 [27, 49, 50] . The pleiotropic actions of CKLF2 in normal muscle growth and regeneration suggest a crucial role for this protein in multiple steps of the myogenic program. We purpose that in injured muscle, just like IGF-1 [51] , CKLF2 is transiently induced to stimulate the proliferation of quiescent satellite cells to enter the cell cycle and to promote the differentiation of satellite cells when they reach confluence. Subsequent studies also have indicated similar stimulatory effects of mouse CKLF2 on C2C12 cells. This indicates that the enhancing effect of CKLF2 on the muscle regeneration may be evolutionarily conserved.
In summary, we have demonstrated that CKLF2 could stimulate the proliferation and differentiation of C2C12 skeletal muscle cells. So, CKLF2 may play a pivotal role in regulation of development and regeneration of skeletal muscle. As we have known, many growth factors including FGF and HGF are required for migration, proliferation and differentiation of embryonic myogenic precursor cells. CKLF2 may be one of such factors. So, extensive studies on CKLF2 function on skeletal muscle will be helpful in uncovering the operating mechanisms and networks controlling the development and regeneration of skeletal muscle.
